突破性治疗药*CDE

**Breakthrough Therapies** The Center for Drug Evaluation (CDE) is responsible for the review and approval of new drugs and medical devices in China. The CDE's Breakthrough Therapies program is designed to expedite the development and review of new drugs that have the potential to treat serious or life-threatening conditions. **Highlights of the Breakthrough Therapies program:** * Fast-track review process * Increased communication between the CDE and drug developers * Access to early patient access programs * Potential for accelerated approval The Breakthrough Therapies program has the potential to make new treatments available to patients more quickly and efficiently.